Limited tickets remain for A Night to Strike Out Rare Cancer at Fenway Park on May 2! Learn more.×
Donate
« Video Library

Dr Brian Alexander, CEO of Foundation Medicine, discusses the role of serial blood testing in TRACK.

Dr. Brian Alexander, CEO of Foundation Medicine, speaks about the importance of serial blood testing in the TRACK Study, as well as its unique importance in rare cancers.